logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11364311 B1

PDFFull Text
Date of Patent:
Jun. 21, 2022

Filed:

Nov. 06, 2018

Method of identifying asd phenotype 1 patients

Applicant:

Stalicla S.a., Geneva, CH;

Inventor:

Lynn Durham, Geneva, CH;

Assignee:

Stalicla S.A., Geneva, CH;

Attorneys:

Millen, White, Zelano & Branigan, PC

Ryan Pool

Primary Examiner:

Lianko G Garyu

Int. Cl.
CPC ...
A61P 25/00 (2006.01); A61K 49/00 (2006.01); A61K 31/26 (2006.01); A61K 31/196 (2006.01); A61K 31/27 (2006.01); A61K 31/366 (2006.01); A61K 31/44 (2006.01); A61K 38/45 (2006.01); A61P 43/00 (2006.01); A61K 36/31 (2006.01); A61K 31/555 (2006.01); A61K 31/335 (2006.01); A61K 31/05 (2006.01); A61K 31/047 (2006.01); A61K 31/11 (2006.01); A61K 31/497 (2006.01); A61K 31/225 (2006.01); A61K 31/122 (2006.01); A61K 38/06 (2006.01); A61K 31/10 (2006.01); A61K 31/155 (2006.01); A61K 31/192 (2006.01); A61K 31/203 (2006.01); A61K 31/343 (2006.01); A61K 31/352 (2006.01); A61K 31/365 (2006.01); A61K 31/375 (2006.01); A61K 31/4409 (2006.01); A61K 31/4425 (2006.01); A61K 36/062 (2006.01); A61K 38/17 (2006.01); A61B 5/16 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0004 (2013.01); A61B 5/167 (2013.01); A61K 31/047 (2013.01); A61K 31/05 (2013.01); A61K 31/10 (2013.01); A61K 31/11 (2013.01); A61K 31/122 (2013.01); A61K 31/155 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/203 (2013.01); A61K 31/225 (2013.01); A61K 31/26 (2013.01); A61K 31/27 (2013.01); A61K 31/335 (2013.01); A61K 31/343 (2013.01); A61K 31/352 (2013.01); A61K 31/365 (2013.01); A61K 31/366 (2013.01); A61K 31/375 (2013.01); A61K 31/44 (2013.01); A61K 31/4409 (2013.01); A61K 31/4425 (2013.01); A61K 31/497 (2013.01); A61K 31/555 (2013.01); A61K 36/062 (2013.01); A61K 36/31 (2013.01); A61K 38/063 (2013.01); A61K 38/1706 (2013.01); A61K 38/1709 (2013.01); A61K 38/45 (2013.01); A61P 25/00 (2018.01); A61P 43/00 (2018.01);
Abstract

The present invention is directed to a method of identifying autism spectrum disorder (ASD) phenotype 1 patients, wherein the method comprises: administering an Nrf2-activator to an ASD patient previously diagnosed with idiopathic ASD or a subject displaying clinical signs of ASD, and identifying the ASD patient as an ASD phenotype 1 patient if the patient shows a negative response after administration of the Nrf2-activator. Likewise, the present invention is directed to a method for classifying autism spectrum disorder (ASD) phenotype 1 patients, the method comprising: administering an Nrf2-activator to a subject, and observing if the subject shows a negative response after administration of the Nrf2-activator, in which the subject is a patient previously diagnosed with idiopathic ASD or a subject displaying clinical signs of ASD and in which the negative response supports classification of the subject as an ASD phenotype 1 patient.

Find Patent Forward Citations

Durham, Lynn. (2022). Method of identifying asd phenotype 1 patients (U.S. Patent No. 11364311). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11364311

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…